87 related articles for article (PubMed ID: 305703)
21. Lupus Nephritis. Correlations between the clinical course and presence of electron-dense deposits.
Dillard MG; Tillman RL; Sampson CC
Lab Invest; 1975 Mar; 32(3):261-9. PubMed ID: 1123909
[TBL] [Abstract][Full Text] [Related]
22. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
23. [Role of T and B lymphocytes in the pathogenesis of systemic lupus erythematosus].
Gliński W
Przegl Dermatol; 1976; 63(4):505-12. PubMed ID: 788057
[No Abstract] [Full Text] [Related]
24. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
[TBL] [Abstract][Full Text] [Related]
25. The course of lupus nephritis: a clinical-pathological correlation of fifty patients.
Striker GE; Kelly MR; Quadracci LJ; Scribner BH
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1141-66. PubMed ID: 4803308
[No Abstract] [Full Text] [Related]
26. Activation of glomerular basement membrane-specific B cells in the renal draining lymph node after T cell-mediated glomerular injury.
Robertson J; Wu J; Arends J; Zhou C; McMahon J; Torres L; Lou YH
J Am Soc Nephrol; 2005 Nov; 16(11):3256-63. PubMed ID: 16162812
[TBL] [Abstract][Full Text] [Related]
27. [Cellular hypersensitivity in some therapeutic diseases].
Traianova TG
Ter Arkh; 1977; 49(7):11-20. PubMed ID: 302502
[No Abstract] [Full Text] [Related]
28. The clinical course of lupus nephritis: relationship to the renal histologic findings.
Pollak VE; Pirani CL; Dujovne I; Dillard MG
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
[No Abstract] [Full Text] [Related]
29. [Changes in the cellular-humoral immune reactivity of patients with lupus nephritis and chronic glomerulonephritis treated with corticosteroids or corticosteroids and imuran].
Stefanova G; Mikhaĭlova A; Gavrilov G; Naumova E; Bŭchvarova E
Vutr Boles; 1983; 22(5):65-71. PubMed ID: 6673336
[TBL] [Abstract][Full Text] [Related]
30. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
Lavalle C; Alcocer J; Gudiño J; Fraga A
Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
[TBL] [Abstract][Full Text] [Related]
31. [Lupus nephritis: clinicomorphological manifestations (author's transl)].
Torras A; Vallés M; Darnell A; Mirapeix E; Revert L
Med Clin (Barc); 1980 Jun; 75(1):1-9. PubMed ID: 7392705
[TBL] [Abstract][Full Text] [Related]
32. Cellular immunity in systemic lupus erythematosus.
Boumpas DT; Eleftheriades EG; Tsokos GC
In Vivo; 1988; 2(1):41-5. PubMed ID: 2979815
[TBL] [Abstract][Full Text] [Related]
33. Immunological response to glomerular basement membrane and streptococcal antigensin immunized rabbits.
Wheeler J; Holland J; Menzies S; Blainey JD
Immunology; 1975 Apr; 28(4):653-8. PubMed ID: 807519
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
35. Glomerular deposition of renal tubular epithelial antigen in patients with systemic lupus erythematosus: its possible role in lupus nephritis.
Gilboa N; Durante D; McIntosh RM
J Rheumatol; 1977; 4(4):358-68. PubMed ID: 604475
[TBL] [Abstract][Full Text] [Related]
36. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
37. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
38. [Study of lupus nephritis by means of fluorescent antibody technic. I. Study of cases with deposits of gamma G- and beta 1C-globulins in the glomerular basement membrane and nucleus].
Nagasawa T; Kitamura K; Shibata S
Arerugi; 1970 Nov; 19(11):818-23. PubMed ID: 4099059
[No Abstract] [Full Text] [Related]
39. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
40. [Study of the peripheral blood lymphocytes in systemic lupus erythematosus of different degree of activity].
Bulanova TD; Speranskiĭ AI; Gordovskaia NB; Ivanova MM
Ter Arkh; 1978; 50(9):94-8. PubMed ID: 309188
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
